author_facet Vatner, Stephen F.
Vatner, Stephen F.
author Vatner, Stephen F.
spellingShingle Vatner, Stephen F.
Circulation Research
Why So Few New Cardiovascular Drugs Translate to the Clinics
Cardiology and Cardiovascular Medicine
Physiology
author_sort vatner, stephen f.
spelling Vatner, Stephen F. 0009-7330 1524-4571 Ovid Technologies (Wolters Kluwer Health) Cardiology and Cardiovascular Medicine Physiology http://dx.doi.org/10.1161/circresaha.116.309512 Why So Few New Cardiovascular Drugs Translate to the Clinics Circulation Research
doi_str_mv 10.1161/circresaha.116.309512
facet_avail Online
Free
finc_class_facet Medizin
Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS9jaXJjcmVzYWhhLjExNi4zMDk1MTI
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS9jaXJjcmVzYWhhLjExNi4zMDk1MTI
institution DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
imprint Ovid Technologies (Wolters Kluwer Health), 2016
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2016
issn 0009-7330
1524-4571
issn_str_mv 0009-7330
1524-4571
language English
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
match_str vatner2016whysofewnewcardiovasculardrugstranslatetotheclinics
publishDateSort 2016
publisher Ovid Technologies (Wolters Kluwer Health)
recordtype ai
record_format ai
series Circulation Research
source_id 49
title Why So Few New Cardiovascular Drugs Translate to the Clinics
title_unstemmed Why So Few New Cardiovascular Drugs Translate to the Clinics
title_full Why So Few New Cardiovascular Drugs Translate to the Clinics
title_fullStr Why So Few New Cardiovascular Drugs Translate to the Clinics
title_full_unstemmed Why So Few New Cardiovascular Drugs Translate to the Clinics
title_short Why So Few New Cardiovascular Drugs Translate to the Clinics
title_sort why so few new cardiovascular drugs translate to the clinics
topic Cardiology and Cardiovascular Medicine
Physiology
url http://dx.doi.org/10.1161/circresaha.116.309512
publishDate 2016
physical 714-717
description
container_issue 6
container_start_page 714
container_title Circulation Research
container_volume 119
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792333087499091972
geogr_code not assigned
last_indexed 2024-03-01T14:07:10.454Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Why+So+Few+New+Cardiovascular+Drugs+Translate+to+the+Clinics&rft.date=2016-09-02&genre=article&issn=1524-4571&volume=119&issue=6&spage=714&epage=717&pages=714-717&jtitle=Circulation+Research&atitle=Why+So+Few+New+Cardiovascular+Drugs+Translate+to+the+Clinics&aulast=Vatner&aufirst=Stephen+F.&rft_id=info%3Adoi%2F10.1161%2Fcircresaha.116.309512&rft.language%5B0%5D=eng
SOLR
_version_ 1792333087499091972
author Vatner, Stephen F.
author_facet Vatner, Stephen F., Vatner, Stephen F.
author_sort vatner, stephen f.
container_issue 6
container_start_page 714
container_title Circulation Research
container_volume 119
description
doi_str_mv 10.1161/circresaha.116.309512
facet_avail Online, Free
finc_class_facet Medizin, Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS9jaXJjcmVzYWhhLjExNi4zMDk1MTI
imprint Ovid Technologies (Wolters Kluwer Health), 2016
imprint_str_mv Ovid Technologies (Wolters Kluwer Health), 2016
institution DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15
issn 0009-7330, 1524-4571
issn_str_mv 0009-7330, 1524-4571
language English
last_indexed 2024-03-01T14:07:10.454Z
match_str vatner2016whysofewnewcardiovasculardrugstranslatetotheclinics
mega_collection Ovid Technologies (Wolters Kluwer Health) (CrossRef)
physical 714-717
publishDate 2016
publishDateSort 2016
publisher Ovid Technologies (Wolters Kluwer Health)
record_format ai
recordtype ai
series Circulation Research
source_id 49
spelling Vatner, Stephen F. 0009-7330 1524-4571 Ovid Technologies (Wolters Kluwer Health) Cardiology and Cardiovascular Medicine Physiology http://dx.doi.org/10.1161/circresaha.116.309512 Why So Few New Cardiovascular Drugs Translate to the Clinics Circulation Research
spellingShingle Vatner, Stephen F., Circulation Research, Why So Few New Cardiovascular Drugs Translate to the Clinics, Cardiology and Cardiovascular Medicine, Physiology
title Why So Few New Cardiovascular Drugs Translate to the Clinics
title_full Why So Few New Cardiovascular Drugs Translate to the Clinics
title_fullStr Why So Few New Cardiovascular Drugs Translate to the Clinics
title_full_unstemmed Why So Few New Cardiovascular Drugs Translate to the Clinics
title_short Why So Few New Cardiovascular Drugs Translate to the Clinics
title_sort why so few new cardiovascular drugs translate to the clinics
title_unstemmed Why So Few New Cardiovascular Drugs Translate to the Clinics
topic Cardiology and Cardiovascular Medicine, Physiology
url http://dx.doi.org/10.1161/circresaha.116.309512